Infants and Children Under 12 Given the Pfizer mRNA COVID “Vaccine” Seven Months Before Pediatric Approval. 71% Suffered Serious Adverse Events.

By Dr. Barbara Gehrett, Dr. Joseph Gehrett, Dr. Chris Flowers, and Loree Britt
Global Research, February 01, 2023
DailyClout 31 January 2023
Theme:

All Global Research articles can be read in 51 languages by activating the Translate Website button below the author’s name.

To receive Global Research’s Daily Newsletter (selected articles), click here.

Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

***

The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt – produced a shocking review of the paediatric data found in

[Confidential[Pfizer document [released under FOI in October 2021] entitled: 

5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., “5.3.6“).

It is important to note

1) that the adverse events (AEs) in the 5.3.6 document were reported to Pfizer for only a 90-day period starting on December 1, 2020, the date of the United Kingdom’s public rollout of Pfizer’s COVID-19 experimental mRNA “vaccine” product and

2) no pediatric dose of the Pfizer product was approved for use during that time frame.

What dose(s) of Pfizer’s mRNA “vaccine” was given to these children since no approved dose existed?

Important points from this report include:

  • A seven-year-old experienced a stroke.
  • One child and one infant suffered facial paralysis.
  • One infant had a kidney adverse event, either kidney injury or failure.
  • Of the 34 cases, 24 (71%) were classified as serious.
  • Predominantly female patients were affected — at least 25 of 34 (73.5%) patients.
  • Table 6 reports 34 cases of use in pediatric individuals. However, 28 additional cases were excluded because details such as height and weight were “not consistent with pediatric subjects.”
  • Ages ranged from two months to nine years, with median 4.0 years, which means half the children were under four years of age.
  • 132 adverse events were reported in the 34 children – i.e., an average of 3.88 AEs per child.

Shockingly, Pfizer concluded:

“No new significant safety information was identified based on a review of these cases compared with the non-paediatric population.”

Please read the disturbing, two-page report by the Post-Marketing Group (Team 1) here.

*

Note to readers: Please click the share buttons above. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

Featured image is from The Expose

The Worldwide Corona Crisis, Global Coup d’Etat Against Humanity

by Michel Chossudovsky

Michel Chossudovsky reviews in detail how this insidious project “destroys people’s lives”. He provides a comprehensive analysis of everything you need to know about the “pandemic” — from the medical dimensions to the economic and social repercussions, political underpinnings, and mental and psychological impacts.

“My objective as an author is to inform people worldwide and refute the official narrative which has been used as a justification to destabilize the economic and social fabric of entire countries, followed by the imposition of the “deadly” COVID-19 “vaccine”. This crisis affects humanity in its entirety: almost 8 billion people. We stand in solidarity with our fellow human beings and our children worldwide. Truth is a powerful instrument.”

ISBN: 978-0-9879389-3-0,  Year: 2022,  PDF Ebook,  Pages: 164, 15 Chapters

Price: $11.50 Get yours for FREE! Click here to download.

We encourage you to support the eBook project by making a donation through Global Research’s DonorBox “Worldwide Corona Crisis” Campaign Page. 

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]